Skip to main content
. 2017 Feb 9;32:e2017004. doi: 10.5620/eht.e2017004

Figure 1.

Figure 1.

Uterine appearances in response to (A) control, (B) 17β -estradiol 10 µg/kg/d, (C) ZP 2 mg/kg/d, (D) ZP 10 mg/kg/d, and (E) ZP 50 mg/ kg/d. ZP, zinc pyrithione.